为优化在西弗吉尼亚州阿片类药物使用障碍患者的布普伦诺芬治疗中保持治疗的实施机会
Roman Ivasiy1, Lynn M Madden2, Judith Feinberg3
1Yale School of Medicine, Department of Internal Medicine, Section of Infectious Diseases, New Haven, CT, USA; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT, USA.
Drug and alcohol dependence
|October 17, 2025
概括
较高的布普伦诺芬剂量和较长的初始处方持续时间显著改善了患者在阿片类药物使用障碍治疗中的保留. 调整处方实践,特别是在开始时,对于打击阿片类药物危机至关重要.
科学领域:
- 成 药物 药物 药物 药物
- 公共卫生 公共卫生
- 药物治疗 药物治疗
背景情况:
- 西弗吉尼亚州面临着美国最高的过量死亡率.
- 布普伦诺芬治疗对阿片类药物使用障碍 (OUD) 有效.
- 患者的保留是成功OUD治疗结果的关键.
研究的目的:
- 为了调查现实世界的布普伦诺芬处方实践.
- 为了确定影响患者在OUD治疗中留住患者的因素.
- 为改善治疗结果提供临床实践的信息.
主要方法:
- 对西弗吉尼亚处方药监测计划数据 (2022) 的分析.
- 包括6686名开始接受布普伦诺芬治疗的个人.
- 使用具有马脆弱性的比例危险模型来评估停止治疗的风险.
主要成果:
- 较高的布普伦诺芬初始剂量 (≥8mg) 和较长的初始处方持续时间 (≥7天) 显著降低了停药风险.
- 时间依赖分析显示,较高剂量 (≥16mg) 和较长时间供应 (≥28天) 的保护作用增加.
- 年龄较小,男性性别和自付费与更高的戒断相关;公共保险降低了风险.
结论:
- 增加布普伦诺芬剂量和延长带回家供应大大提高了患者的留守率.
- 临床医生应该优化处方策略,特别是在治疗开始时.
- 这些发现为减轻西弗吉尼亚州阿片类药物危机提供了可操作的见解.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Opioid Analgesics: Synthetic and Semisynthetic Opioids
908
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
908
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
232
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
232
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
249
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
249
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K


